Department of Anaesthesia & Pain Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
J Clin Epidemiol. 2012 Aug;65(8):817-26. doi: 10.1016/j.jclinepi.2012.02.008. Epub 2012 May 30.
For continuous outcomes measured using instruments with an established minimally important difference (MID), pooled estimates can be usefully reported in MID units. Approaches suggested thus far omit studies that used instruments without an established MID. We describe an approach that addresses this limitation.
Using the ratio of MID to standard deviation in the trials with an established MID, we imputed the MID for instruments without an established MID and pooled across all trials. We applied this approach to two meta-analyses.
In 20 trials of respiratory rehabilitation, the pooled estimate did not differ significantly between trials with an established MID and those without an established MID (interaction P=0.23). The same was true for 52 trials examining amitriptyline vs. other antidepressants (interaction P=0.54). In the respiratory example, the addition of trials without an established MID led to little change in point estimates or confidence intervals (CIs, more data balanced by more heterogeneity in a random effects model). In the antidepressant example, the additional trials resulted in an identical point estimate with a narrowing of the CI.
Our method allows estimates of a pooled effect in MID units using both trials with and without an established MID.
对于使用具有既定最小临床重要差异(MID)的仪器测量的连续性结局,可在 MID 单位中报告汇总估计值。目前提出的方法忽略了使用尚无既定 MID 的仪器的研究。我们描述了一种解决此限制的方法。
利用具有既定 MID 的试验中 MID 与标准差的比值,我们推断出尚无既定 MID 的仪器的 MID,并在所有试验中进行汇总。我们将该方法应用于两项荟萃分析。
在 20 项呼吸康复试验中,具有既定 MID 的试验与尚无既定 MID 的试验之间的汇总估计值无显著差异(交互作用 P=0.23)。对于 52 项比较阿米替林与其他抗抑郁药的试验,情况也是如此(交互作用 P=0.54)。在呼吸示例中,添加尚无既定 MID 的试验仅使点估计值或置信区间(CI,在随机效应模型中更多数据由更多异质性平衡)略有变化。在抗抑郁药示例中,附加试验导致 CI 变窄的相同点估计值。
我们的方法允许使用具有和不具有既定 MID 的试验在 MID 单位中报告汇总效应的估计值。